Medical News

RSS

Cholera case confirmed in Dominican Republic; Haitian protestors blame U.N. peacekeeping troops for cholera outbreak

Officials on Tuesday said they had confirmed the first case of cholera in Haiti's neighbor, the Dominican Republic, the Associated Press/Forbes reports

18 Nov 2010

Exelixis reports interim data from phase 2 RDT trial for epithelial ovarian cancer

Exelixis, Inc. today reported interim data from the cohort of patients with advanced epithelial ovarian cancer, primary peritoneal, or fallopian tube carcinoma treated with XL184 in an ongoing phase 2 adaptive randomized discontinuation trial (RDT).

18 Nov 2010

Merck announces FDA Advisory Committee approval of GARDASIL for anal cancer and AIN treatment

Merck announced today that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee has advised that the data presented support an indication for GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] for the prevention of anal cancer and anal intraepithelial neoplasia (AIN) in both males and females 9 through 26 years of age.

18 Nov 2010

Inovio achieves positive results in Phase I PENNVAX-B study for HIV

Inovio Pharmaceuticals, Inc. , a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it has achieved high vaccine-induced response rates and strong magnitude of immune responses in its Phase I clinical study of PENNVAX-B, a DNA vaccine for the prevention of HIV infection.

18 Nov 2010

FAO report highlights 'alarmingly' high food price increases, forecasts food import bills could exceed $1T in 2010

International food import bills could exceed $1 trillion in 2010, the U.N. Food and Agriculture Organization (FAO) said Wednesday in its Food Outlook report, which found that wheat and other food staple prices have increased alarmingly over the past year, the Associated Press reports.

18 Nov 2010

Gore launches new internet cloud-based 3D advanced visualization and decision support system

W. L. Gore & Associates today announced the introduction of the GORE® 3D Imaging System, a new internet cloud-based 3D advanced visualization and decision support system that will change the paradigm of pre-case planning. The revolutionary new system, which is on exhibit at the VEITHsymposium (37th Annual Symposium on Vascular and Endovascular Issues), reflects Gore's ongoing commitment to supporting physicians in making informed treatment decisions.

18 Nov 2010

Clinical trial shows dalfampridine tablets improve walking ability in MS patients

Acorda Therapeutics, Inc. today announced that data from the second of two pivotal dalfampridine extended release tablets Phase 3 clinical trials in multiple sclerosis (MS) were published in the October 2010 edition of Annals of Neurology.

18 Nov 2010

Center for Medicare and Medicaid Innovation launches projects to improve care, reduce cost

Kaiser Health News: "Promising fast action, the new Center for Medicare and Medicaid Innovation is launching a series of initiatives aimed at improving medical care while reducing its cost, officials said Tuesday. ... In one initiative, eight states will participate in a Medicare demonstration project to evaluate the effectiveness of doctors and other health professionals working 'in a more integrated fashion and receiving more coordinated payment,' according to CMS, the parent agency of the center and a part of the Department of Health and Human Services.

18 Nov 2010

Researchers discover NG2+ cells may impact ALS disease progression

By tracking the fate of a group of immature cells that persist in the adult brain and spinal cord, Johns Hopkins researchers discovered in mice that these cells undergo dramatic changes in ALS, also known as Lou Gehrig's disease.

18 Nov 2010

COPD Biomarkers Qualification Consortium launched

The COPD Foundation announces the launch of an unprecedented collaborative effort to pool information on Chronic Obstructive Pulmonary Disease (COPD): the COPD Biomarkers Qualification Consortium (CBQC). The CBQC brings together government agencies, academic institutions and pharmaceutical companies that will share research data on COPD biomarkers—indicators of disease progression/severity.

18 Nov 2010

Neuralstem files NSI-189 IND with FDA for Phase I safety trials for major depression

Neuralstem, Inc. announced that it has filed an Investigational New Drug (IND) application with the United States Food and Drug Administration (FDA) to begin two Phase I safety trials to test NSI-189, its first small molecule compound, for the treatment of major depression. NSI-189 is a proprietary new chemical entity discovered by Neuralstem that stimulates new neuron growth in the hippocampus, an area of the brain that is believed to be involved in depression.

18 Nov 2010

Doctor groups urge Congress to grant temporary reprieve from Medicare payment cuts

Doctors' groups are stepping up their pressure on lawmakers to approve another temporary reprieve from Medicare payments cuts scheduled to go into effect next month.

18 Nov 2010

Insurer news: 2010 could be record profit year; Anthem settles underpayment cases

A California health insurer will pay seven hospitals $1.62 million to settle a dispute over alleged underpayments, the Los Angeles Times reports. "Anthem, a unit of health insurance giant WellPoint Inc. of Indianapolis, admitted no wrongdoing and said in a statement that it settled the matter to avoid litigation. Regulators said the problem stemmed from Anthem's process for handling claims.

18 Nov 2010

Researchers reveal mechanism of early-stage anthrax infection

Researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have determined a key mechanism by which Bacillus anthracis bacteria initiate anthrax infection despite being greatly outnumbered by immune system scavenger cells. The finding, made by studying genetically modified mice, adds new detail to the picture of early-stage anthrax infection and supports efforts to develop vaccines and drugs that would block this part of the cycle.

18 Nov 2010

OmniVision commences mass production of OV6930 medical image sensor

OmniVision Technologies, Inc., a leading developer of advanced digital imaging solutions, today announced the initiation of mass production of the ultra-compact, high-performance OV6930. With a packaged footprint of only 1.8 x 1.8 mm, the OV6930 is the ideal solution for applications favoring a small profile.

18 Nov 2010

Myrexis presents data on MPC-9528 cancer metabolism inhibitor at EORTC/NCI/AACR Symposium

Myrexis, Inc., a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today presented two posters at the 22nd European Organisation for Research and Treatment of Cancer (EORTC), National Cancer Institute (NCI) and American Association for Cancer Research (AACR) Symposium on "Molecular Targets and Cancer Therapeutics," in Berlin, Germany.

18 Nov 2010

Researchers unveil novel oncogene associated with uveal melanoma

An international, multi-center study has revealed the discovery of a novel oncogene that is associated with uveal melanoma, the most common form of eye cancer.

18 Nov 2010

Benefits: OMB recoups $687 million across agencies, including Medicare; Department of Labor sues businesses for withholding employee money

The Office of Management and Budget, which has been working to track and recoup the money paid by agencies in the wrong amount or to the wrong vendors and contractors reported "$687 million was recovered across all agencies in Fiscal Year 2010.

18 Nov 2010

5-lipoxygenase protein modulates amyloid beta formation linked to Alzheimer's disease

A protein known to exist in the brain for more than 30 years, called 5-lipoxygenase, has been found to play a regulatory role in the formation of the amyloid beta in the brain, the major component of plaques implicated in the development of Alzheimer's disease, according to researchers at Temple University's School of Medicine.

18 Nov 2010

miR765 RNA may play a role in development of heart failure: Research

Researchers at the University of Cincinnati (UC) have found a potential genetic target for heart disease, which could lead to therapies to prevent the development of the nation's No. 1 killer in its initial stages.

18 Nov 2010

Medical News

Cholera case confirmed in Dominican Republic; Haitian protestors blame U.N. peacekeeping troops for cholera outbreak

Exelixis reports interim data from phase 2 RDT trial for epithelial ovarian cancer

Merck announces FDA Advisory Committee approval of GARDASIL for anal cancer and AIN treatment

Inovio achieves positive results in Phase I PENNVAX-B study for HIV

FAO report highlights 'alarmingly' high food price increases, forecasts food import bills could exceed $1T in 2010

Gore launches new internet cloud-based 3D advanced visualization and decision support system

Clinical trial shows dalfampridine tablets improve walking ability in MS patients

Center for Medicare and Medicaid Innovation launches projects to improve care, reduce cost

Researchers discover NG2+ cells may impact ALS disease progression

COPD Biomarkers Qualification Consortium launched

Neuralstem files NSI-189 IND with FDA for Phase I safety trials for major depression

Doctor groups urge Congress to grant temporary reprieve from Medicare payment cuts

Insurer news: 2010 could be record profit year; Anthem settles underpayment cases

Researchers reveal mechanism of early-stage anthrax infection

OmniVision commences mass production of OV6930 medical image sensor

Myrexis presents data on MPC-9528 cancer metabolism inhibitor at EORTC/NCI/AACR Symposium

Researchers unveil novel oncogene associated with uveal melanoma

Benefits: OMB recoups $687 million across agencies, including Medicare; Department of Labor sues businesses for withholding employee money

5-lipoxygenase protein modulates amyloid beta formation linked to Alzheimer's disease

miR765 RNA may play a role in development of heart failure: Research

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News